The PROSPECT II study was published in the March 13th issue of The Lancet,
finding that IVUS+NIRS imaging can detect plaques at increased risk for future adverse cardiac outcomes.VIEW ARTICLE VIEW ARTICLE
CRT 2020

Infraredx
Activities

Didactic Sessions

Learn more about our groundbreaking technologies through our informative didactic sessions and hands-on demonstrations of the Makoto™ Intravascular Imaging System and the OKAY® II Y-Connector.
Saturday,
February 22,
2:15 PM
Emmanouil Brilakis, MD, PhD

Minneapolis Heart Institute

“Tools & Techniques for CTO Procedures”
Followed by hand-on demonstrations of the OKAY® II Y-Connector

Sunday,
February 23,
10:30 AM
Ryan Madder, MD

Spectrum Health

“Residual Lipid Core Plaque After Stenting? Using NIRS to Assess the Risk of Target Lesion Failure”
Followed by hands-on demos of the Makoto™ Imaging System

Sunday,
February 23,
4:00 PM
Ron Waksman, MD

Medstar Washington Hospital Center

“LRP & Vulnerable Plaque: How will the Lipid-Rich Plaque Study Results Impact Practice”
Followed by hands-on demos of the Makoto™ Imaging System

Monday,
February 24,
1:00 PM
Ziad Ali, MD

Columbia University Medical Center

“Imaging & Interpretation”
Followed by hands-on demos of the Makoto™ Imaging System

12:30 PM
Lunch
12:30 PM
Integrating NIRS in Clinical Practice

Moderator: Takashi Akasaka, MD, PhD
Moderator: Ryan D. Madder, MD
Moderator: Ron Waksman, MD, FSCAI

12:45 PM
Case That – NIRS IVUS Useful to Guide Stenting and Therapy

Speaker: John McB Hodgson, MD, MSCAI

12:53 PM
Review of Early Clinical Experience and Trials With NIRS

Speaker: Ryan D. Madder, MD

1:01 PM
From LRP to Prospect II, How the Emerging Data Will Support Routine Usage of NIRS to Detect Vulnerable Patients and Plaques

Speaker: Carlo Di Mario, MD

1:09 PM
Current Usage of NIRS in Japan

Speaker: Takashi Akasaka, MD, PhD

1:17 PM
Panel Discussion: Integrating NIRS in Clinical Practice

Panel Moderator: Takashi Akasaka, MD, PhD
Panel Moderator: Ryan D. Madder, MD
Panel Moderator: Ron Waksman, MD, FSCAI
Panelist: Carlo Di Mario, MD
Panelist: James A. Goldstein, MD, FSCAI
Panelist: John McB Hodgson, MD, MSCAI

1:30 PM
Adjourn
11:23 AM
Vulnerable Plaque Clinical Trials Update

Moderator: Ryan D. Madder, MD
Moderator: Lorenz Räber, MD, PhD

11:31 AM
Assessment of Stabilization of Plaque Vulnerability by OCT

Speaker: Takashi Akasaka, MD, PhD

11:39 AM
Near-Infrared Spectroscopy: Lipid-Rich Plaque Study – New Data and Implications

Speaker: Ron Waksman, MD, FSCAI

11:47 AM
PROSPECT II and PREVENT Rationale and Update from the Trials

Speaker: Gregg W. Stone, MD, FSCAI

11:55 AM
Detection of Lipid Core Plaque Cap Thickness via Collagen Spectroscopy

Speaker: Robert L. Wilensky, MD

12:03 PM
Detection of Lipid Core Plaque Cap Thickness via Collagen Spectroscopy

Speaker: Robert L. Wilensky, MD

12:11 PM
Panel Discussion: Now That We Can Identify Vulnerable Plaque, What’s Next?

Moderator: Ryan D. Madder, MD
Moderator: Lorenz Räber, MD, PhD
Panelist: Takashi Akasaka, MD, PhD
Panelist: Peter Libby, MD
Panelist: Gregg W. Stone, MD, FSCAI
Panelist: Ron Waksman, MD, FSCAI
Panelist: Robert L. Wilensky, MD

VIEW FULL SCHEDULE

8:40 AM
Interesting NIRS Cases

Speaker: Hector M. Garcia-Garcia, MD, PhD

8:55 AM
Cases of Co-Registration

Speaker: Jasvindar Singh, MD

Introduction to Intravascular Imaging
10:15 AM
Practical Integration of Intravascular Imaging and Physiology into the Cath Lab in 2020

Speaker: Gary S. Mintz, MD

10:33 AM
Intravascular Imaging in the Left Main: IVUS or OCT?

Speaker: Giulio Guagliumi, MD

1:50 PM
Characteristics of Calcified Lesions with Intravascular Imaging and Treatment Approach

Speaker: Giora Weisz, MD

2:00 PM
Intracoronary Near-Infrared Spectroscopy: The Role for NIRS in Detecting Vulnerable Plaques and Vulnerable Patients

Speaker: Ryan D. Madder, MD

VIEW FULL SCHEDULE

Sign up to receive more information

© 2020 Infraredx™, Inc. All Rights Reserved Powered by Bloom Creative